Clearmind Medicine (CMND) news
Recent news
EU clears acquisition of BTZ by CM and Bunge
AInvest Wire · 1d agoClearmind Medicine - Calls for research and clinical collaborations with VA, Dow, and HHS
Clearmind Medicine has recently announced a strategic initiative to expand its research and clinical collaboration efforts, with a focus on partnerships with the U.S. Department of Veterans Affairs (VA), Dow Inc., and the U.S. Department of Health and Human Services (HHS). The company emphasized…
AInvest Wire · 7d agoClearmind advances dialogue with U.S. federal government on psychedelic therapies, submitting recommendations to FDA
Clearmind Medicine (CMND) has continued to engage with the U.S. Food and Drug Administration (FDA) on the development of psychedelic therapies, following recent invitations to participate in key discussions on the future of this emerging field. The company has submitted recommendations to the FDA…
AInvest Wire · 7d agoClearmind Medicine: Effects 1-for-8 reverse share split, effective October 5, 2026
Clearmind Medicine (NasdaqCM: CMND) has announced that a 1-for-8 reverse share split will become effective on October 5, 2026. This corporate action will reduce the total number of outstanding shares by a factor of eight, with shareholders receiving one new share for every eight shares held. The…
AInvest Wire · Sep 30, 2026Clearmind enrolls first patients with alcohol use disorder in CMND-100 clinical trial
AInvest Wire · Sep 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.